Результаты поиска - Stephen Mok

  • Отображение 1 - 17 результаты of 17
Отмена результатов
  1. 1
    Combined treatment with dabrafenib and trametinib with immune-stimulating antibodies for BRAF mutant melanoma

    Combined treatment with dabrafenib and trametinib with immune-stimulating antibodies for BRAF mutant melanoma по Blanca Homet Moreno, Stephen Mok, Begonya Comin-Anduix, Siwen Hu‐Lieskovan, Antoni Ribas

    Опубликовано 2015
    Полный текст Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  2. 2
    Inhibition of colony stimulating factor-1 receptor improves antitumor efficacy of BRAF inhibition

    Inhibition of colony stimulating factor-1 receptor improves antitumor efficacy of BRAF inhibition по Stephen Mok, Jennifer Tsoi, Richard C. Koya, Siwen Hu‐Lieskovan, Brian L. West, Gideon Bollag, Thomas G. Graeber, Antoni Ribas

    Опубликовано 2015
    Полный текст Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  3. 3
    Anti-CTLA-4 generates greater memory response than anti-PD-1 via TCF-1

    Anti-CTLA-4 generates greater memory response than anti-PD-1 via TCF-1 по Stephen Mok, Huey Liu, Didem Ağaç Çobanoğlu, Nana-Ama A.S. Anang, James J. Mancuso, E. John Wherry, James P. Allison

    Опубликовано 2025
    Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  4. 4
    Kinetic phases of distribution and tumor targeting by T cell receptor engineered lymphocytes inducing robust antitumor responses

    Kinetic phases of distribution and tumor targeting by T cell receptor engineered lymphocytes inducing robust antitumor responses по Richard C. Koya, Stephen Mok, Begoña Comı́n-Anduix, Thinle Chodon, Caius G. Radu, Michael I. Nishimura, Owen N. Witte, Antoni Ribas

    Опубликовано 2010
    Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  5. 5
    CSF1R Signaling Blockade Stanches Tumor-Infiltrating Myeloid Cells and Improves the Efficacy of Radiotherapy in Prostate Cancer

    CSF1R Signaling Blockade Stanches Tumor-Infiltrating Myeloid Cells and Improves the Efficacy of Radiotherapy in Prostate Cancer по Jingying Xu, Jemima Escamilla, Stephen Mok, John David, Saul J. Priceman, Brian L. West, Gideon Bollag, William H. McBride, Lily Wu

    Опубликовано 2013
    Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  6. 6
    Inhibition of CSF-1 Receptor Improves the Antitumor Efficacy of Adoptive Cell Transfer Immunotherapy

    Inhibition of CSF-1 Receptor Improves the Antitumor Efficacy of Adoptive Cell Transfer Immunotherapy по Stephen Mok, Richard C. Koya, Christopher Tsui, Jingying Xu, Lídia Robert, Lily Wu, Thomas G. Graeber, Brian L. West, Gideon Bollag, Antoni Ribas

    Опубликовано 2013
    Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  7. 7
    An Effective Immuno-PET Imaging Method to Monitor CD8-Dependent Responses to Immunotherapy

    An Effective Immuno-PET Imaging Method to Monitor CD8-Dependent Responses to Immunotherapy по Richard Tavaré, Helena Escuin-Ordinas, Stephen Mok, Melissa N. McCracken, Kirstin A. Zettlitz, Felix B. Salazar, Owen N. Witte, Antoni Ribas, Anna M. Wu

    Опубликовано 2015
    Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  8. 8
    Distinct immunological mechanisms of CTLA-4 and PD-1 blockade revealed by analyzing TCR usage in blood lymphocytes

    Distinct immunological mechanisms of CTLA-4 and PD-1 blockade revealed by analyzing TCR usage in blood lymphocytes по Lídia Robert, Christina L. Harview, Ryan Emerson, Xiaoyan Wang, Stephen Mok, Blanca Homet, Begonya Comin-Anduix, Richard C. Koya, Harlan Robins, Paul C. Tumeh, Antoni Ribas

    Опубликовано 2014
    Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  9. 9
    Improved antitumor activity of immunotherapy with BRAF and MEK inhibitors in <i>BRAF</i> <sup> <i>V600E</i> </sup> melanoma

    Improved antitumor activity of immunotherapy with BRAF and MEK inhibitors in <i>BRAF</i> <sup> <i>V600E</i> </sup> melanoma по Siwen Hu‐Lieskovan, Stephen Mok, Blanca Homet Moreno, Jennifer Tsoi, Lídia Robert, Lucas Goedert, Elaine M. Pinheiro, Richard C. Koya, Thomas G. Graeber, Begoña Comı́n-Anduix, Antoni Ribas

    Опубликовано 2015
    Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  10. 10
    BRAF Inhibitor Vemurafenib Improves the Antitumor Activity of Adoptive Cell Immunotherapy

    BRAF Inhibitor Vemurafenib Improves the Antitumor Activity of Adoptive Cell Immunotherapy по Richard C. Koya, Stephen Mok, Nicholas Otte, Kevin J. Blacketor, Begonya Comin-Anduix, Paul C. Tumeh, Aspram Minasyan, Nicholas A. Graham, Thomas G. Graeber, Thinle Chodon, Antoni Ribas

    Опубликовано 2012
    Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  11. 11
    CTLA4 Blockade Induces Frequent Tumor Infiltration by Activated Lymphocytes Regardless of Clinical Responses in Humans

    CTLA4 Blockade Induces Frequent Tumor Infiltration by Activated Lymphocytes Regardless of Clinical Responses in Humans по Rong Huang, Jason Jalil, James S. Economou, Bartosz Chmielowski, Richard C. Koya, Stephen Mok, Hooman Sazegar, Elizabeth Seja, Arturo Villanueva, Jesús Gómez-Navarro, John A. Glaspy, Alistair J. Cochran, Antoni Ribas

    Опубликовано 2011
    Полный текст Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  12. 12
    CTLA4 Blockade Broadens the Peripheral T-Cell Receptor Repertoire

    CTLA4 Blockade Broadens the Peripheral T-Cell Receptor Repertoire по Lídia Robert, Jennifer Tsoi, Xiaoyan Wang, Ryan Emerson, Blanca Homet, Thinle Chodon, Stephen Mok, Rong Huang, Alistair J. Cochran, Begoña Comı́n-Anduix, Richard C. Koya, Thomas G. Graeber, Harlan Robins, Antoni Ribas

    Опубликовано 2014
    Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  13. 13
    Antitumor effects of the investigational selective MEK inhibitor TAK733 against cutaneous and uveal melanoma cell lines

    Antitumor effects of the investigational selective MEK inhibitor TAK733 against cutaneous and uveal melanoma cell lines по Erika von Euw, Mohammad Atefi, Narsis Attar, Connie Chu, Sybil Zachariah, Barry L. Burgess, Stephen Mok, Charles Ng, Deborah J. Wong, Bartosz Chmielowski, David I. Lichter, Richard C. Koya, Tara A. McCannel, Elena S. Izmailova, Antoni Ribas

    Опубликовано 2012
    Полный текст Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  14. 14
    Host immunity contributes to the anti-melanoma activity of BRAF inhibitors

    Host immunity contributes to the anti-melanoma activity of BRAF inhibitors по Deborah A. Knight, Shin Foong Ngiow, Ming Li, Tiffany J. Parmenter, Stephen Mok, Ashley Cass, Nicole M. Haynes, Kathryn M. Kinross, Hideo Yagita∥, Richard C. Koya, Thomas G. Graeber, Antoni Ribas, Grant A. McArthur, Mark J. Smyth

    Опубликовано 2013
    Полный текст Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  15. 15
    Enhanced Antitumor Activity Induced by Adoptive T-Cell Transfer and Adjunctive Use of the Histone Deacetylase Inhibitor LAQ824

    Enhanced Antitumor Activity Induced by Adoptive T-Cell Transfer and Adjunctive Use of the Histone Deacetylase Inhibitor LAQ824 по Dan D. Vo, Robert M. Prins, Jonathan L. Begley, Timothy R. Donahue, Lilah F. Morris, Kevin W. Bruhn, Pilar de la Rocha, Meng-Yin Yang, Stephen Mok, Hermes Garbán, Noah Craft, James S. Economou, Francesco M. Marincola, Ena Wang, Antoni Ribas

    Опубликовано 2009
    Полный текст Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  16. 16
    Differential sensitivity of melanoma cell lines with BRAF V600E mutation to the specific Raf inhibitor PLX4032

    Differential sensitivity of melanoma cell lines with BRAF V600E mutation to the specific Raf inhibitor PLX4032 по Jonas Nørskov Søndergaard, Ramin Nazarian, Qi Wang, Deliang Guo, Teli Hsueh, Stephen Mok, Hooman Sazegar, Laura E. MacConaill, Jordi Barretina, Sarah M. Kehoe, Narsis Attar, Erika von Euw, Jonathan E. Zuckerman, Bartosz Chmielowski, Begoña Comı́n-Anduix, Richard C. Koya, Paul S. Mischel, Roger S. Lo, Antoni Ribas

    Опубликовано 2010
    Полный текст Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  17. 17
    <i>RAS</i>Mutations in Cutaneous Squamous-Cell Carcinomas in Patients Treated with BRAF Inhibitors

    <i>RAS</i>Mutations in Cutaneous Squamous-Cell Carcinomas in Patients Treated with BRAF Inhibitors по Fei Su, Amaya Virós, Carla Milagre, Kerstin Trunzer, Gideon Bollag, Olivia Spleiss, Jorge S. Reis‐Filho, Xiangju Kong, Richard C. Koya, Keith T. Flaherty, Paul B. Chapman, Min Jung Kim, Robert Hayward, Matthew J. Martin, Hong Yang, Qiongqing Wang, Holly Hilton, Julie S. Hang, Johannes Noé, Maryou Lambros, Felipe C. Geyer, Nathalie Dhomen, Ion Niculescu‐Duvaz, Alfonso Zambon, Dan Niculescu‐Duvaz, Natasha Preece, Lídia Robert, Nicholas Otte, Stephen Mok, Damien Kee, Yan Ma, Chao Zhang, Gaston Habets, Elizabeth A. Burton, Bernice H. Wong, Hoa Nguyen, Mark Kockx, Luc Andries, Brian Lestini, K. B. Nolop, Richard J. Lee, Andrew K. Joe, James L. Troy, René González, Thomas E. Hutson, Igor Puzanov, Bartosz Chmielowski, Caroline J. Springer, Grant A. McArthur, Jeffrey A. Sosman, Roger S. Lo, Antoni Ribas, Richard Marais

    Опубликовано 2012
    Полный текст Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:

Инструменты поиска: